EuropaBio Convention 2003
Organisers announce keynote speakers and chairs for world-class conference programme
CORDIAs organisers have today confirmed the keynote plenary speakers and primary conference session Chairs for their first annual convention in Vienna, 2-4 December 2003. Through a world-class conference, exhibition and partnering forum, CORDIA is set to become the industrys largest biotech convention in Europe for trade, investment, partnership and information exchange. Full details of this exciting new conference are available at www.cordiaconvention.com.
Some of the most influential figures in the life sciences industry will open the conference with the theme Bringing Knowledge to Life: Europes Life Science Opportunity on a Global Scale. The keynote speakers include:
Professor Leena Peltonen, Chair, Department of Molecular Medicine, National Public Health Institute, Finland
Feike Sijbesma, Chairman EuropaBio, Member of the Board of DSM, The Netherlands
Dr Philippe Pouletty, Vice-Chairman EuropaBio, President France Biotech, France
Ysbrand Poortman, Chairman, European Platform for Patients Organisations, Science and Industry (EPPOSI), The Netherlands
The keynote speakers will put Europes key assets under the microscope from a political, scientific, social and industrial perspective, and will present a framework for improving the global competiveness of the European biotechnology community and for meeting societys needs more effectively.
The keynote speakers will address the burning issues of the day:
The need for a regulatory environment to enable the biotech industry to bring new biomedical solutions to patients, and to foster the industrys contribution to a sustainable economy;
The need to double effort and investment in bioscientific education and research to ensure Europe fosters and retains its many talents and attracts the best ones from abroad;
Improving financial measures to stimulate the creation and growth of young innovative companies.
Despite Europes excellence and initial lead in biosciences, North America is now leading the way in turning breakthrough discoveries into revenue generating applications. One of CORDIAs aims is to foster the right environment to enable Europes biotechnology community to compete globally on a level playing field, said Mr. Hugo Schepens, Secretary General, EuropaBio.
For the first time outside North America, CORDIA offers delegates and exhibitors the opportunity to learn from and do business with some the worlds most respected names in the life sciences industry, added Schepens.
This is the toughest environment the majority of European life science companies have yet faced; the timing of CORDIA as a learning and business forum could not be more important for the sector and has been an important motivator in developing the Conference programme, added Dr Helen Abbott, Senior Consultant at Technomark.
Overall, the conference programme features some 300 speakers in 60 parallel sessions which are divided into five streams dedicated to addressing the catalysts and barriers to growth and innovation in the healthcare, agriculture, industrial and environmental sectors.
Key conference Chairs include:
Steen Riisgaard, CEO Novozymes, Denmark
Andrea Rappagliosi, Vice President Corporate Health Policy & Government Relations, Serono International SA, Switzerland
Dr Erik Tambuyzer, Senior VP Corporate Affairs Europe, Genzyme Corporation, Belgium
Dr Alun McCarthy, Director Clinical Pharmacogenetics, GSK, UK
Prof. Friedrich Dorner, President Global R&D, Baxter BioScience, Austria
Prof. Helmut Bachmayer, Head Corporate Biosafety, Novartis Research Institute, Austria
Prof. Alexander von Gabain, CEO, Intercell AG, Austria
Dr Hans Kast, President & CEO, BASF Plant Science Holding GmbH, Germany
Denis Lucquin, General Partner, Sofinnova Partners, France
Dr Karen Bernstein, Editor-in-Chief, BioCentury, USA
Dr Philippe Archinard, CEO, Innogenetics, Belgium
Prof. Frank Gannon, Executive Director, EMBO, Heidelberg
Dr Paul Haycock, Director, Apax Partners, UK
Jean-Francois Mouney, CEO, Genfit, France
Prof. Linda Nielsen, Rector, Copenhagen University, Denmark
Dr Jean-Loup Romet-Lemonne, CEO, IDM, France
Dr Dinko Valerio, CEO, CruCell, The Netherlands
CORDIAs Partnering Forum offers a unique and cost-effective environment for emerging and maturing biotech companies to showcase their science and technology breakthroughs to potential business partners and investors globally.
CORDIA’’S exhibition will combine National Pavilions from Europe, the US and Asia, with independent stands featuring leading biotech and pharmaceutical companies, and key industry advisors including VCs, lawyers and consultants. Europes leading Biotech Associations and member companies have already taken over 50% of the floorspace and the remaining space is selling out fast. Leading names exhibiting at the event include DSM, Bristol-Myers Squibb, Genzyme, GSK, Quintiles and Avecia.
Till C. Jelitto | alfa